Top 30 Companies in Global Gene Transfer Technologies Market (2025–2035): Competitive Analysis And Forecast
RELEASE DATE: Sep 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Gene Transfer Technologies Market Size is projected to Grow from USD 3.70 Billion in 2024 to USD 10.18 Billion by 2035, at a CAGR of 9.64% during the forecast period 2025–2035. The market for Gene Transfer Technologies is growing demand due to growing investment in biotechnology research, expanding use in vaccine development, and increasing need for novel cancer treatments, developing personalized medicine, and growing gene therapy applications.
Introduction
The Gene Transfer Technologies Market Size encompasses the global industry involved in the development, production, and commercialization of technologies that enable the transfer of genetic material into cells. These technologies play a critical role in gene therapy, genetic engineering, and molecular biology research by facilitating the modification of cellular functions for therapeutic, diagnostic, and research purposes. The market growth for gene transfer technologies is being driven primarily by the increasing need for tailored medications, cell and gene therapies, and increased applications in vaccine development and cancer immunotherapy. One of the main factors propelling the market expansion for gene transfer technologies is the growing use in vaccine development and cancer immunotherapy applications.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights - Download the Brochure now and dive deeper into the future of the Gene Transfer Technologies Market.
Gene Transfer Technologies Market Size & Statistics
- The Market Size for Gene Transfer Technologies Was estimated to be worth USD 3.70 Billion in 2024.
- The Market Size is going to Expand at a CAGR of 9.64% between 2025 and 2035.
- The Global Gene Transfer Technologies Market Size is anticipated to reach USD 10.18 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Gene Transfer Technologies Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Gene Transfer Technologies Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Gene Transfer Technologies market.
The Asia Pacific region is projected to have the fastest growing CAGR for both Next Generation Sequencing (NGS) and Gene Transfer Technologies (GTT) markets due to increased government funding and investment in genomics research, rising prevalence of chronic and genetic diseases, rapid expansion of healthcare infrastructure, and strategic initiatives by major market players to develop and provide advanced technologies to meet growing demand.
North America is expected to generate the highest demand during the forecast period in the Gene Transfer Technologies market.
North America dominates the Gene Transfer Technologies market due to its strong pharmaceutical and biotechnology sectors, significant investments in research and development, robust regulatory frameworks, and advanced healthcare infrastructure. The presence of leading companies, increasing funding for genetic medicine, a growing prevalence of genetic disorders, and advancements in viral vector technologies and gene editing further drive North America's market leadership.
Top 7 Trends in the Gene Transfer Technologies Market
- Growth of Personalized Medicine and Cell & Gene Therapies
- Increased Investment and Funding
- Advancements in Gene Editing
- Expanding Clinical Pipeline & Regulatory Approvals
- Expansion of Manufacturing Infrastructure
- Rising Demand for Viral Vectors
- Expanding Therapeutic Applications
1. Growth of Personalized Medicine and Cell & Gene Therapies
There is increasing demand for customized treatments, with gene therapy becoming a cornerstone for treating genetic disorders, rare diseases, and cancers, driving the development of new delivery systems and manufacturing processes.
2. Increased Investment and Funding
The market is witnessing significant financial commitment from biopharma companies and private equity, fueling research and development efforts and the scale-up of commercial ventures in gene therapy.
3. Advancements in Gene Editing
Technologies like CRISPR-Cas9, TALEN, ZFN, and base editing are improving the precision and efficiency of gene transfer, enabling the creation of novel treatments for genetic conditions previously considered untreatable.
4. Expanding Clinical Pipeline & Regulatory Approvals
A robust clinical trial pipeline and an increasing number of regulatory approvals demonstrate the growing clinical and commercial viability of gene therapies, accelerating their path to market.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Gene Transfer Technologies market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 7 Companies Leading the Gene Transfer Technologies Market
- Novartis
- Pfizer
- Gilead Sciences
- CRISPR Therapeutics
- Intellia Therapeutics
- Editas Medicine
- UniQure
- Others
1. Novartis
Headquarters: Switzerland
Novartis is a significant player in the gene transfer technologies market, focusing on developing and commercializing gene therapies for rare and life-threatening genetic diseases, particularly through its Novartis Gene Therapies division (formerly AveXis). Their flagship product is Zolgensma, a gene therapy approved for spinal muscular atrophy (SMA). Novartis uses a combination of AAV (adeno-associated virus)-based vectors and CRISPR technologies in its research, and has expanded its pipeline through acquisitions and strategic partnerships, including deals with Voyager Therapeutics, to improve delivery to hard-to-reach organs.
2. Pfizer
Headquarters: U.S.
Pfizer has largely exited the gene therapy market after discontinuing its hemophilia B gene therapy Beqvez in February 2025 due to weak demand and low sales, following earlier exits from its Duchenne muscular dystrophy (DMD) candidate and a hemophilia A gene therapy program. This withdrawal marks a significant shift from its previous strategy of investing in and developing gene therapies for rare diseases, leading to the disposal of its gene therapy assets.
3.Gilead Sciences
Headquarters: U.S.
Gilead Sciences is a major player in the gene transfer technologies market, particularly through its Kite Pharma acquisition, which solidified its position in CAR T-cell therapies for cancer. The company is also involved in developing other gene-based therapies for viral diseases, including its early work with oligonucleotides (a form of gene therapy) for HIV, and through its 2025 acquisition of Interius Pharmaceuticals, advancing in vivo cell therapy technologies.
4. CRISPR Therapeutics
Headquarters: Switzerland
CRISPR Therapeutics is a leading company developing gene editing-based medicines, making it a key player in the rapidly growing gene transfer technologies market, which is driven by the rising prevalence of genetic disorders and increasing investments in the biotechnology sector. The CRISPR market, particularly gene editing, is experiencing substantial growth with various market research firms projecting significant expansion over the next decade, fueled by advancements in precision gene editing and its wide-ranging therapeutic potential across diseases like hemoglobinopathies, cancer, and rare conditions.
Are you ready to discover more about the Gene Transfer Technologies market?
The report provides an in-depth analysis of the leading companies operating in the global Gene Transfer Technologies market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Novartis
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Pfizer
- Gilead Sciences
- CRISPR Therapeutics
- Intellia Therapeutics
- Editas Medicine
- UniQure
- Others
Conclusion
The gene transfer technologies market is poised for significant growth, driven by key advancements and strategic market dynamics. The industry is experiencing an expansion fueled by the rising demand for personalized medicine and cell and gene therapies, as well as substantial increases in investment and funding. Leading companies in the sector, such as Novartis, Gilead Sciences, and CRISPR Therapeutics, are actively shaping the market through a focus on gene-editing technologies and therapeutic applications. While North America currently holds a dominant position due to its robust infrastructure and strong R&D, the Asia Pacific region is projected to be the fastest-growing market, indicating a shift in global demand. This rapid evolution and the continuous expansion of therapeutic applications suggest a promising and dynamic future for gene transfer technologies.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?